BD GlaspakRecalls & reported problems across all models
Becton, Dickinson And Company · 2 models in the FDA device registry
Data updated Oct 18, 2026 from official FDA records · Editorial policy
2 open recalls name at least one BD Glaspak model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls
- 2
We found 2 models of BD Glaspak by Becton, Dickinson And Company in the FDA's device registry (GUDID). Together they are named in 4 adverse event reports in the FDA's MAUDE database, received between Aug 7, 2018 and Jun 24, 2022 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Manufacturing, Packaging or Shipping Problem” (2 reports).
2 FDA recall records name at least one of these models by its device identifier, 2 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works
BD Glaspak recalls
FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.
- Apr 27, 2026Class IOpen, Classified
This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
Z-2255-2026 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗
- Apr 27, 2026Class IOpen, Classified
This is a sub-recall of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. The recall is due to quality issues identified during an FDA manufacturing facility inspection, citing specific quality deficiencies related to acceptance testing.
Z-2250-2026 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗
Most reported BD Glaspak problems
Device problems
- Manufacturing, Packaging or Shipping Problem2
- Patient-Device Incompatibility1
- Volume Accuracy Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- No Consequences Or Impact To Patient1
- No Information1
BD Glaspak models
2 models, most reported first. Each model has its own page with its reports, recalls and device details.
- BD Glaspak 405675Anesthesia conduction kit1 recall3 reports
- BD Glaspak 405632Anesthesia conduction kit1 recall1 report
Recent BD Glaspak adverse event reports
The 4 most recent reports across all models, in the reporter's own words as published by the FDA.
MalfunctionJun 24, 2022Patient-Device Incompatibility; Patient-Device Incompatibility
IT WAS REPORTED THAT THE BD GLASPAK SPINAL ANESTHESIA TRAY FAILED TO WORK. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WE HAVE A SPECIFIC LOT OF BD SPINAL TRAYS WHERE THE DRUGS IN THE TRAY DID NOT WORK AS INTENDED FOR THE ANESTHESIOLOGIST.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14799649 ↗MalfunctionJul 30, 2021Volume Accuracy Problem; Volume Accuracy Problem
IT WAS REPORTED TRAY SPN WHIT25G3.5 25G1.5 L/B-D/E WAS LABELED INCORRECTLY, WITH FILL MARKINGS INCORRECTLY PLACED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "HASH MARKS ON 5ML SYRINGE IN EPIDURAL KIT DO NOT LINE UP WITH THE HUB/BASE OF THE SYRINGE. THIS COULD HAVE RESULTED IN DELIVERING APPROX 1ML ADDITIONAL MEDICATION THAN INTENDED. ANESTHESIOLOGIST, DR , NOTED ISSUE UPON DRAWING UP MEDICATION AND HANDED OFF MIS-MARKED SYRINGE IMMEDIATELY. NEW KIT OPENED--SAME MANUF NUMBER, SAME LOT NUMBER BUT THE SYRINGE WITHIN WAS CORRECT."
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12256194 ↗MalfunctionMar 15, 2019Manufacturing, Packaging or Shipping Problem
IT WAS REPORTED THAT THE TRAY SPN QNKE26G3.5 L/B-D WAS NOTICED TO HAVE INCORRECT CONTENT WITHIN IT BEFORE USE, AS IT DID NOT CONTAIN "BUPIVACAINE". AS REPORTED BY THE CUSTOMER, "PER CUSTOMER, REPORTED THE PACK HAD THE WRONG CONTENTS IN THE PACK. THE PACK THEY RECEIVED DID NOT CONTAIN BUPIVACAINE."
Patient problems: No Information
MAUDE report 8425372 ↗MalfunctionAug 7, 2018Manufacturing, Packaging or Shipping Problem
IT WAS REPORTED THAT THE PACKAGED BD WHITACRE SPINAL TRAYS HAD DIFFERENT ITEMS IN THE TRAYS AND WERE MISSING TWO DRUGS. THERE WAS NO REPORT OF EXPOSURE, INJURY, OR MEDICAL INTERVENTION NOTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7759834 ↗
Other Becton, Dickinson And Company products
- BD Vacutainer SST10 models · 4,985 reports · 3 recalls
- BD Luer-Lok48 models · 5,117 reports
- BD Insyte Autoguard33 models · 4,465 reports · 8 recalls
- BD SafetyGlide17 models · 2,185 reports
- BD Vacutainer Eclipse Blood Collection Needle4 models · 1,880 reports
- BD Vacutainer Push Button Blood Collection Set9 models · 1,831 reports
- BD Nexiva25 models · 1,614 reports · 1 recall
- BD BACTEC MGIT Mycobacteria Growth Indicator Tubes2 models · 1,554 reports
Sources and updates
- Models: FDA GUDID, file dated Oct 13, 2026. Models are grouped by the brand name the manufacturer registered.
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page